Literature DB >> 3801273

Localisation of lung cancer by a radiolabelled monoclonal antibody against the c-myc oncogene product.

S Y Chan, G I Evan, A Ritson, J Watson, P Wraight, K Sikora.   

Abstract

A set of mouse nonoclonal antibodies against the c-myc oncogene product, a 62,000 dalton nuclear binding protein involved in cell cycle control, has been constructed by immunisation with synthetic peptide fragments. One such antibody, CT14, was radiolabelled with 131I and administered to 20 patients with different malignant diseases. Good tumour localisation was observed in 12 out of 14 patients with primary bronchial carcinoma but not in patients with pulmonary metastases from primary tumours elsewhere. Successfully localised tumours were all 3 cm or more in diameter. Monoclonal antibodies against oncogene products may provide novel selective tools for the diagnosis and therapy of cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3801273      PMCID: PMC2001543          DOI: 10.1038/bjc.1986.238

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

Review 1.  Cellular transforming genes and oncogenesis.

Authors:  G M Cooper; M A Lane
Journal:  Biochim Biophys Acta       Date:  1984

Review 2.  Cancer genes come of age.

Authors:  J M Bishop
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

3.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

Authors:  K Kelly; B H Cochran; C D Stiles; P Leder
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

4.  Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: implications for embryonic cell proliferation.

Authors:  S Pfeifer-Ohlsson; A S Goustin; J Rydnert; T Wahlström; L Bjersing; D Stehelin; R Ohlsson
Journal:  Cell       Date:  1984-09       Impact factor: 41.582

5.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines.

Authors:  C D Little; M M Nau; D N Carney; A F Gazdar; J D Minna
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

6.  Expression of cellular oncogenes in human malignancies.

Authors:  D J Slamon; J B deKernion; I M Verma; M J Cline
Journal:  Science       Date:  1984-04-20       Impact factor: 47.728

Review 7.  The emerging genetics of human cancer.

Authors:  T G Krontiris
Journal:  N Engl J Med       Date:  1983-08-18       Impact factor: 91.245

8.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

9.  Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.

Authors:  P H Rabbitts; J V Watson; A Lamond; A Forster; M A Stinson; G Evan; W Fischer; E Atherton; R Sheppard; T H Rabbitts
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

10.  Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody.

Authors:  H M Smedley; P Finan; E S Lennox; A Ritson; F Takei; P Wraight; K Sikora
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

View more
  5 in total

1.  c-myc coded oncoprotein for immunotargeting. Oropharyngeal and other tumors at S.N. Medical College, Agra, India.

Authors:  V L Lahiri; D K Hazra; B R Elhence; B Mukerji; G Kalra; V Mehrotra; K Singh
Journal:  Cell Biophys       Date:  1992 Aug-Dec

2.  Inhibition of the hepatocyte uptake of radiolabelled monoclonal antibodies by chelating agents.

Authors:  B R Davidson; P B Boulos; J B Porter
Journal:  Eur J Nucl Med       Date:  1990

3.  Immunoscintigraphy of human lung squamous cell carcinoma using an iodine-131 labelled monoclonal antibody (Po66).

Authors:  P Bourguet; L Dazord; B Desrues; B Collet; M P Ramee; P Delaval; A Martin; Y Logeais; A Pelletier; L Toujas
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

4.  The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.

Authors:  B R Davidson; J Babich; H Young; W Waddington; G Clarke; M Short; P Boulos; J Styles; C Dean
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

Review 5.  Genes and cancer: a clinical perspective.

Authors:  M Ellis; K Sikora
Journal:  J R Coll Physicians Lond       Date:  1987-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.